Tilray Brands, Inc.
TLRYHealthcareNASDAQDrug Manufacturers - Specialty & Generic
Scan Results
Daily timeframeTilray Brands, Inc., a lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, the. At a $643.5M market cap, Tilray Brands, Inc. ranks as a small-cap company within healthcare. The company operates through four segments: Beverage, Cannabis, Distribution, and Wellness.
Market Cap
$643.5M
Beta
1.94
P/E (TTM)
—
P/E (Fwd)
19.84
EPS (TTM)
$-14.63
EPS (Fwd)
$0.27
ROE
-63.2%
ROA
-1.5%
Cash
$425.7M
Total Debt
$343.9M
Free CF
-$31.1M
52W Change
31.2%
Annual Financials
Cash vs Debt
Tilray Brands, Inc. holds $425.7M in cash against $343.9M in total debt, giving it a net cash position. This means the company could theoretically pay off all its debt and still have cash remaining. The company is burning cash, with free cash flow at -$31.1M. This typically occurs when a company is investing aggressively in growth, but sustained cash burn can strain the balance sheet. Return on equity stands at -63.2%, which is negative for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. Revenue has grown from $628.4M (2022) to $821.3M (2025), reflecting a 31% increase over the period.
A beta of 1.94 means TLRY is more volatile than average. Investors should be prepared for wider price swings relative to broader indices. Negative free cash flow means the company is currently spending more than it generates, which may require future fundraising or debt if the trend continues. It is important to consider these factors alongside broader market conditions and individual financial goals when reviewing TLRY.